239 related articles for article (PubMed ID: 9224654)
21. A CACCC box in the proximal exon 2 promoter of the rat insulin-like growth factor I gene is required for basal promoter activity.
Wang X; Talamantez JL; Adamo ML
Endocrinology; 1998 Mar; 139(3):1054-66. PubMed ID: 9492038
[TBL] [Abstract][Full Text] [Related]
22. De novo expression of the Muc2 gene in pancreas carcinoma cells is triggered by promoter demethylation.
Siedow A; Szyf M; Gratchev A; Kobalz U; Hanski ML; Bumke-Vogt C; Foss HD; Riecken EO; Hanski C
Tumour Biol; 2002; 23(1):54-60. PubMed ID: 11893907
[TBL] [Abstract][Full Text] [Related]
23. Promoter of the canine tracheobronchial mucin gene.
Verma M; Murthy VV; Mathew S; Banerji D; Kurl RN; Olnes MJ; Yankaskas JR; Blass C; Davidson EA
Glycoconj J; 1996 Oct; 13(5):797-807. PubMed ID: 8910007
[TBL] [Abstract][Full Text] [Related]
24. Tissue-specific expression of the vasoactive intestinal peptide gene requires both an upstream tissue specifier element and the 5' proximal cyclic AMP-responsive element.
Hahm SH; Eiden LE
J Neurochem; 1996 Nov; 67(5):1872-81. PubMed ID: 8863492
[TBL] [Abstract][Full Text] [Related]
25. Platelet-derived growth factor A-chain gene transcription is mediated by positive and negative regulatory regions in the promoter.
Kaetzel DM; Maul RS; Liu B; Bonthron D; Fenstermaker RA; Coyne DW
Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):321-7. PubMed ID: 8042973
[TBL] [Abstract][Full Text] [Related]
26. Goblet cell-specific expression mediated by the MUC2 mucin gene promoter in the intestine of transgenic mice.
Gum JR; Hicks JW; Gillespie AM; Carlson EJ; Kömüves L; Karnik S; Hong JC; Epstein CJ; Kim YS
Am J Physiol; 1999 Mar; 276(3):G666-76. PubMed ID: 10070043
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the infection-responsive bovine lactoferrin promoter.
Zheng J; Ather JL; Sonstegard TS; Kerr DE
Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
[TBL] [Abstract][Full Text] [Related]
28. Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene.
Aoki K; Kato J; Shoemaker MT; Moss J
Gene; 2005 May; 351():83-95. PubMed ID: 15893437
[TBL] [Abstract][Full Text] [Related]
29. Mucin mRNA expression in lung adenocarcinoma cell lines and tissues.
Yu CJ; Yang PC; Shew JY; Hong TM; Yang SC; Lee YC; Lee LN; Luh KT; Wu CW
Oncology; 1996; 53(2):118-26. PubMed ID: 8604237
[TBL] [Abstract][Full Text] [Related]
30. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites.
Golubovskaya V; Kaur A; Cance W
Biochim Biophys Acta; 2004 May; 1678(2-3):111-25. PubMed ID: 15157737
[TBL] [Abstract][Full Text] [Related]
31. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection.
Burger-van Paassen N; Vincent A; Puiman PJ; van der Sluis M; Bouma J; Boehm G; van Goudoever JB; van Seuningen I; Renes IB
Biochem J; 2009 May; 420(2):211-9. PubMed ID: 19228118
[TBL] [Abstract][Full Text] [Related]
32. Cloning of the rat insulin-like growth factor-binding protein-2 gene and identification of a functional promoter lacking a TATA box.
Brown AL; Rechler MM
Mol Endocrinol; 1990 Dec; 4(12):2039-51. PubMed ID: 1707131
[TBL] [Abstract][Full Text] [Related]
33. Aberrant expression of human mucin gene MUC5B in gastric carcinoma and cancer cells. Identification and regulation of a distal promoter.
Perrais M; Pigny P; Buisine MP; Porchet N; Aubert JP; Van Seuningen-Lempire I
J Biol Chem; 2001 May; 276(18):15386-96. PubMed ID: 11278696
[TBL] [Abstract][Full Text] [Related]
34. Initiation of transcription of the MUC3A human intestinal mucin from a TATA-less promoter and comparison with the MUC3B amino terminus.
Gum JR; Hicks JW; Crawley SC; Dahl CM; Yang SC; Roberton AM; Kim YS
J Biol Chem; 2003 Dec; 278(49):49600-9. PubMed ID: 12958310
[TBL] [Abstract][Full Text] [Related]
35. Role of site-specific promoter hypomethylation in aberrant MUC2 mucin expression in mucinous gastric carcinomas.
Mesquita P; Peixoto AJ; Seruca R; Hanski C; Almeida R; Silva F; Reis C; David L
Cancer Lett; 2003 Jan; 189(2):129-36. PubMed ID: 12490305
[TBL] [Abstract][Full Text] [Related]
36. Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas.
Konduri SD; Osman FA; Rao CN; Srinivas H; Yanamandra N; Tasiou A; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Kouraklis G; Rao JS
Oncogene; 2002 Jan; 21(6):921-8. PubMed ID: 11840337
[TBL] [Abstract][Full Text] [Related]
37. Structure of the human 5-HT7 receptor gene and characterization of its promoter region.
Laenen K; Haegeman G; Vanhoenacker P
Gene; 2007 Apr; 391(1-2):252-63. PubMed ID: 17321075
[TBL] [Abstract][Full Text] [Related]
38. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium.
Ho SB; Shekels LL; Toribara NW; Kim YS; Lyftogt C; Cherwitz DL; Niehans GA
Cancer Res; 1995 Jun; 55(12):2681-90. PubMed ID: 7780985
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the human interleukin-5 gene promoter: involvement of octamer binding sites in the gene promoter activity.
Gruart-Gouilleux V; Engels P; Sullivan M
Eur J Immunol; 1995 May; 25(5):1431-5. PubMed ID: 7774647
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the regulatory regions of the human aromatase (P450arom) gene involved in placenta-specific expression.
Kamat A; Alcorn JL; Kunczt C; Mendelson CR
Mol Endocrinol; 1998 Nov; 12(11):1764-77. PubMed ID: 9817601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
